- Home
- SPB vs CVAC Comparison
SPB vs CVAC Comparison
Compare SPB & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPB
- CVAC
- Stock Information
- Founded
- SPB 1906
- CVAC 2000
- Country
- SPB United States
- CVAC Germany
- Employees
- SPB N/A
- CVAC N/A
- Industry
- SPB Industrial Machinery/Components
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- SPB Miscellaneous
- CVAC Health Care
- Exchange
- SPB Nasdaq
- CVAC Nasdaq
- Market Cap
- SPB 1.3B
- CVAC 1.2B
- IPO Year
- SPB N/A
- CVAC 2020
- Fundamental
- Price
- SPB $53.36
- CVAC $5.34
- Analyst Decision
- SPB Strong Buy
- CVAC Hold
- Analyst Count
- SPB 4
- CVAC 3
- Target Price
- SPB $80.75
- CVAC $6.83
- AVG Volume (30 Days)
- SPB 380.8K
- CVAC 482.2K
- Earning Date
- SPB 08-07-2025
- CVAC 11-11-2025
- Dividend Yield
- SPB 3.51%
- CVAC N/A
- EPS Growth
- SPB N/A
- CVAC N/A
- EPS
- SPB 2.71
- CVAC 1.01
- Revenue
- SPB $2,849,200,000.00
- CVAC $599,540,810.00
- Revenue This Year
- SPB N/A
- CVAC N/A
- Revenue Next Year
- SPB $0.42
- CVAC $24.04
- P/E Ratio
- SPB $19.79
- CVAC $5.30
- Revenue Growth
- SPB N/A
- CVAC 675.15
- 52 Week Low
- SPB $50.73
- CVAC $2.37
- 52 Week High
- SPB $96.62
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- SPB 42.74
- CVAC 42.37
- Support Level
- SPB $53.69
- CVAC $5.33
- Resistance Level
- SPB $58.36
- CVAC $5.41
- Average True Range (ATR)
- SPB 1.49
- CVAC 0.04
- MACD
- SPB -0.25
- CVAC -0.01
- Stochastic Oscillator
- SPB 0.20
- CVAC 15.38
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.